Protective peptides derived from novel glial proteins

D. E. Brenneman, C. Y. Spong, I. Gozes

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

In studying the mediators of VIP neurotrophism in the central nervous system, two glial proteins have been discovered. Both of these proteins contain short peptides that exhibit femtomolar potency in preventing neuronal cell death from a wide variety of neurotoxic substances. Extension of these peptides to models of oxidative stress or neurodegeneration in vivo have indicated significant efficacy in protection. These peptides, both as individual agents and in combination, have promise as possible protective agents in the treatment of human neurodegenerative disease and in pathologies involving oxidative stress.

Original languageEnglish (US)
Pages (from-to)452-455
Number of pages4
JournalBiochemical Society Transactions
Volume28
Issue number4
DOIs
StatePublished - Jan 1 2000
Externally publishedYes

Fingerprint

Neuroglia
Oxidative stress
Peptides
Oxidative Stress
Neurodegenerative diseases
Protective Agents
Proteins
Neurology
Pathology
Cell death
Neurodegenerative Diseases
Cell Death
Central Nervous System

Keywords

  • Activity-dependent neuroprotective protein
  • Activity-dependent neurotrophic factor
  • Astrocytes
  • Cell death
  • Vasoactive intestinal peptide

ASJC Scopus subject areas

  • Biochemistry

Cite this

Protective peptides derived from novel glial proteins. / Brenneman, D. E.; Spong, C. Y.; Gozes, I.

In: Biochemical Society Transactions, Vol. 28, No. 4, 01.01.2000, p. 452-455.

Research output: Contribution to journalArticle

Brenneman, D. E. ; Spong, C. Y. ; Gozes, I. / Protective peptides derived from novel glial proteins. In: Biochemical Society Transactions. 2000 ; Vol. 28, No. 4. pp. 452-455.
@article{973f5c0b018747ae9f0b10a31705510c,
title = "Protective peptides derived from novel glial proteins",
abstract = "In studying the mediators of VIP neurotrophism in the central nervous system, two glial proteins have been discovered. Both of these proteins contain short peptides that exhibit femtomolar potency in preventing neuronal cell death from a wide variety of neurotoxic substances. Extension of these peptides to models of oxidative stress or neurodegeneration in vivo have indicated significant efficacy in protection. These peptides, both as individual agents and in combination, have promise as possible protective agents in the treatment of human neurodegenerative disease and in pathologies involving oxidative stress.",
keywords = "Activity-dependent neuroprotective protein, Activity-dependent neurotrophic factor, Astrocytes, Cell death, Vasoactive intestinal peptide",
author = "Brenneman, {D. E.} and Spong, {C. Y.} and I. Gozes",
year = "2000",
month = "1",
day = "1",
doi = "10.1042/bst0280452",
language = "English (US)",
volume = "28",
pages = "452--455",
journal = "Biochemical Society Transactions",
issn = "0300-5127",
publisher = "Portland Press Ltd.",
number = "4",

}

TY - JOUR

T1 - Protective peptides derived from novel glial proteins

AU - Brenneman, D. E.

AU - Spong, C. Y.

AU - Gozes, I.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - In studying the mediators of VIP neurotrophism in the central nervous system, two glial proteins have been discovered. Both of these proteins contain short peptides that exhibit femtomolar potency in preventing neuronal cell death from a wide variety of neurotoxic substances. Extension of these peptides to models of oxidative stress or neurodegeneration in vivo have indicated significant efficacy in protection. These peptides, both as individual agents and in combination, have promise as possible protective agents in the treatment of human neurodegenerative disease and in pathologies involving oxidative stress.

AB - In studying the mediators of VIP neurotrophism in the central nervous system, two glial proteins have been discovered. Both of these proteins contain short peptides that exhibit femtomolar potency in preventing neuronal cell death from a wide variety of neurotoxic substances. Extension of these peptides to models of oxidative stress or neurodegeneration in vivo have indicated significant efficacy in protection. These peptides, both as individual agents and in combination, have promise as possible protective agents in the treatment of human neurodegenerative disease and in pathologies involving oxidative stress.

KW - Activity-dependent neuroprotective protein

KW - Activity-dependent neurotrophic factor

KW - Astrocytes

KW - Cell death

KW - Vasoactive intestinal peptide

UR - http://www.scopus.com/inward/record.url?scp=0033857628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033857628&partnerID=8YFLogxK

U2 - 10.1042/bst0280452

DO - 10.1042/bst0280452

M3 - Article

C2 - 10961938

AN - SCOPUS:0033857628

VL - 28

SP - 452

EP - 455

JO - Biochemical Society Transactions

JF - Biochemical Society Transactions

SN - 0300-5127

IS - 4

ER -